In addition to infectious and genetic conditions, NLRP3 activation contributes to the development of neurogenerative disorders, Alzheimer’s disease [139, 204], Parkinson’s disease [205], cancer [206–212], atherosclerosis [140], gout [79], inflammatory bowel disease (IBD) [206, 213–215], liver diseases [216–219], obesity [216], rheumatoid arthritis [220], and type 2 diabetes [221]. This evidence concerns the gene NLRP3 and cancer.